Startups
Draupnir Bio

Developer of oral, small molecule degrades for extracellular disease-causing proteins.

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 23,000 COMPANIES →

Summary

Seedtable Score

Score icon 64

Locations

Company Size

  • 11 - 51

Last Stage Round

Industry

Total Funding
$46.2M
Investors
Full Company Profile